Invesco Ltd. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$4,447,000
-59.6%
29,416
-61.0%
0.00%
-66.7%
Q2 2022$11,002,000
-37.3%
75,513
-49.0%
0.00%
-25.0%
Q1 2022$17,541,000
-43.5%
147,932
-34.4%
0.00%
-42.9%
Q4 2021$31,058,000
+53.2%
225,365
+54.4%
0.01%
+40.0%
Q3 2021$20,276,000
+161.7%
145,961
+82.9%
0.01%
+150.0%
Q2 2021$7,748,000
+774.5%
79,807
+515.7%
0.00%
Q1 2021$886,000
-0.2%
12,962
+25.1%
0.00%
Q4 2020$888,000
+309.2%
10,358
+211.2%
0.00%
Q3 2020$217,000
-81.0%
3,328
-78.7%
0.00%
Q2 2020$1,142,000
-91.7%
15,630
-93.8%
0.00%
-100.0%
Q4 2019$13,756,000
+26.3%
252,670
-3.2%
0.00%
+33.3%
Q3 2019$10,895,000
+18.8%
261,139
+24.7%
0.00%
+50.0%
Q2 2019$9,171,000
-5.8%
209,433
+10.7%
0.00%
-33.3%
Q1 2019$9,734,000
+25.9%
189,121
-9.5%
0.00%0.0%
Q4 2018$7,730,000
+933.4%
209,041
+654.0%
0.00%
Q4 2017$748,00027,7230.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders